(for various applications, in medicine, pharmaceutical, nutraceutical, cosmeceutical industries and more)
13:30 - 14:15
Key note: Marine Microbiome as a Source of Anticancer Compounds
State of the art in marine biotechnology is being applied to drug discovery under the experience of PharmaMar, a spanish company focused in research, development and commercialization of marine derived drugs for the treatment of cancer.
Genomic mining for polyketide synthases (PKS) and non ribosomal peptide synthetases (NRPS) improves the probability of success in drug discovery using marine microorganisms, both in isolated genomes and metagenomes
Computational genome mining tools for the discovery of bacterial natural products
Prof. Nadine Ziemert will introduce computational tools developed by the Ziemert lab to help prioritise bacterial strains with novel natural products and biosynthetic gene clusters that encode antibiotics.